ACT LOGO 2500x2500 - White.png

  • About

    • Faculty

  • Patient Information

    • Newsletter

  • Sponsors

    • Facilities
    • Capabilities
    • Virtual Tour

  • Studies

    • Asthma
    • Celiac Disease
    • Chronic Cough
    • CMV Vaccine
    • High Blood Pressure
    • High Cholesterol
    • Migraines
    • Nexplanon
    • Oral Birth Control
    • Osteroarthritis
    • Postherpetic Neuralgia
    • Rheumatoid Arthritis
    • Type II Diabetes

  • Media

    • Videos
    • Press Releases

  • Contact

    • Patient Sign Up

  • More

    Use tab to navigate through the menu items.
    Newspaper

    Our latest press releases and

    resources for media

    ​

    Here you will find a range of resources including press releases and updates on approved medications that we have contributed to, and information on our social media channels

     

    ACT News

    ​​

    • Albuquerque Clinical Trials awarded Full Accreditation by the Association of the Accreditation of Human Research Protection Programs, Inc (AAHRPP) 

    ​

    ​​

    ​​

    ​​

    ​

    Sponsor​ News

    ​

    • Merck's Gefapixant (45 mg Twice Daily) Significantly Decreased Cough Frequency Compared to Placebo at Week 12 and 24 in Patients with Refractory or Unexplained Chronic Cough

    ​

    • Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women’s Health

    ​​

     

    ACT Social Media

    ACT - Full Color Symbol.png

    711 Encino Place NE

    Albuquerque, NM 87102

    Directions

    ​

    Telephone: 505-224-7407

    Fax: 505-224-2710

    About Us

    Contact Us

    Patient Information

    Sponsors

    • Facebook
    • Instagram

    © 2021 Albuquerque Clinical Trials, Inc. | All right reserved